Page 123 - கண் இமை மயிர்களுக்கு ஊட்டப்படும் ஒரு வகை சாய கலவை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Remyelinating drug shows potential to improve vision in patients with MS A team led by a biomedical scientist at the University of California, Riverside, reports a drug an estrogen receptor ligand called indazole chloride (IndCl) has the potential to improve vision in patients with multiple sclerosis, or MS. The study, performed on mice induced with a model of MS and the first to investigate IndCl s effect on the pathology and function of the complete afferent visual pathway, is published in Brain Pathology. The afferent visual pathway includes the eyes, optic nerve, and all brain structures responsible for receiving, transmitting, and processing visual information.

United statesRiverside schoolSeema tiwari woodruffJohna katzenellenbogenEmily hendersonUniversity of californiaUniversity of illinois at urbana champaignUc riverside school of medicineMultiple sclerosisImmune systemMouse modelOptic neuritisஒன்றுபட்டது மாநிலங்களில்ஆற்றங்கரை பள்ளிசீமா திவாரி வூட்ரஃப்எமிலி ஹென்டர்சன்